City of Hope researchers ID how most common breast cancer becomes resistant to treatment
Understanding how tumors in patients with early-stage estrogen receptor positive breast cancer evolve to resist certain combination therapies can aid in the design of optimal drug strategies for people whose cancer potentially could be cured
Published 2021-06-24 · Original archive entry · Explore research explainers
DUARTE, Calif. -- City of Hope, a world-renowned cancer research and treatment center, has identified how cancer cells in patients with early-stage breast cancer change and become resistant to hormone or combination therapies, according to a END